Literature DB >> 28725649

Inducible pluripotent stem cells and pulmonary arterial hypertension: the future is now!

Monica Romero Lopez1, Vinicio de Jesus Perez1.   

Abstract

Entities:  

Year:  2017        PMID： 28725649      PMCID： PMC5503909          DOI： 10.21037/sci.2017.05.10

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  9 in total

1.  Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.

Authors:  Mingxia Gu; Ning-Yi Shao; Silin Sa; Dan Li; Vittavat Termglinchan; Mohamed Ameen; Ioannis Karakikes; Gustavo Sosa; Fabian Grubert; Jaecheol Lee; Aiqin Cao; Shalina Taylor; Yu Ma; Zhixin Zhao; James Chappell; Rizwan Hamid; Eric D Austin; Joseph D Gold; Joseph C Wu; Michael P Snyder; Marlene Rabinovitch
Journal:  Cell Stem Cell       Date:  2016-12-22       Impact factor: 24.633

Review 2.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 3.  Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.

Authors:  Sébastien Bonnet; Steeve Provencher; Christophe Guignabert; Frédéric Perros; Olivier Boucherat; Ralph Theo Schermuly; Paul M Hassoun; Marlene Rabinovitch; Mark R Nicolls; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

4.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.

Authors:  Feng Lan; Andrew S Lee; Ping Liang; Veronica Sanchez-Freire; Patricia K Nguyen; Li Wang; Leng Han; Michelle Yen; Yongming Wang; Ning Sun; Oscar J Abilez; Shijun Hu; Antje D Ebert; Enrique G Navarrete; Chelsey S Simmons; Matthew Wheeler; Beth Pruitt; Richard Lewis; Yoshinori Yamaguchi; Euan A Ashley; Donald M Bers; Robert C Robbins; Michael T Longaker; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

5.  Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.

Authors:  Silin Sa; Mingxia Gu; James Chappell; Ning-Yi Shao; Mohamed Ameen; Kathryn A T Elliott; Dan Li; Fabian Grubert; Caiyun G Li; Shalina Taylor; Aiqin Cao; Yu Ma; Ryan Fong; Long Nguyen; Joseph C Wu; Michael P Snyder; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 8.  Pluripotent stem cells in disease modelling and drug discovery.

Authors:  Yishai Avior; Ido Sagi; Nissim Benvenisty
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-28       Impact factor: 94.444

9.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.

Authors:  Jonathan D W Evans; Barbara Girerd; David Montani; Xiao-Jian Wang; Nazzareno Galiè; Eric D Austin; Greg Elliott; Koichiro Asano; Ekkehard Grünig; Yi Yan; Zhi-Cheng Jing; Alessandra Manes; Massimiliano Palazzini; Lisa A Wheeler; Ikue Nakayama; Toru Satoh; Christina Eichstaedt; Katrin Hinderhofer; Matthias Wolf; Erika B Rosenzweig; Wendy K Chung; Florent Soubrier; Gérald Simonneau; Olivier Sitbon; Stefan Gräf; Stephen Kaptoge; Emanuele Di Angelantonio; Marc Humbert; Nicholas W Morrell
Journal:  Lancet Respir Med       Date:  2016-01-19       Impact factor: 30.700
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.